Variant report

Variant	rs1557833
Chromosome Location	chr22:30636331-30636332
allele	A/C
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-HORMAD2-1	chr22:30635936-30636527	ENSG00000232530.1

Extended variants
information (count: 14 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:7)

rs_ID	r²[population]
rs13054238	0.91[ASN][1000 genomes]
rs2267153	0.87[CHB][hapmap]
rs3753082	0.96[ASN][1000 genomes]
rs3761427	0.87[CHB][hapmap]
rs929271	0.91[CHB][hapmap];1.00[JPT][hapmap];0.96[ASN][1000 genomes]
rs929273	0.95[CHB][hapmap];1.00[JPT][hapmap];0.92[ASN][1000 genomes]
rs9606708	0.86[CHB][hapmap]

Variant overlapped rSNPs/rCNVs (count:7 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv834173	chr22:30515092-30658277	Enhancers ZNF genes & repeats Active TSS Weak transcription Transcr. at gene 5' and 3' Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Strong transcription Bivalent/Poised TSS Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	26 gene(s)	inside rSNPs	diseases
2	nsv432239	chr22:30580161-30669883	Enhancers Flanking Active TSS Weak transcription Active TSS Strong transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	25 gene(s)	inside rSNPs	diseases
3	nsv829171	chr22:30598030-31043578	Active TSS Weak transcription Flanking Active TSS Enhancers Genic enhancers Strong transcription Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	66 gene(s)	inside rSNPs	diseases
4	nsv914968	chr22:30610570-30693581	Flanking Bivalent TSS/Enh Strong transcription Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription Active TSS Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	24 gene(s)	inside rSNPs	diseases
5	nsv914969	chr22:30619599-30691631	Enhancers Weak transcription Flanking Active TSS Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	24 gene(s)	inside rSNPs	diseases
6	nsv914970	chr22:30619599-30850395	Active TSS Enhancers Genic enhancers Flanking Active TSS Weak transcription Bivalent Enhancer Bivalent/Poised TSS Strong transcription Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	51 gene(s)	inside rSNPs	diseases
7	nsv834174	chr22:30619760-30746915	Enhancers Strong transcription Weak transcription Genic enhancers Flanking Active TSS Active TSS Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	24 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:66 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr22:30625200-30637000	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
2	chr22:30630800-30636600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
3	chr22:30631400-30637400	Weak transcription	Fetal Brain Male	brain
4	chr22:30631400-30639800	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
5	chr22:30631400-30641600	Weak transcription	Right Atrium	heart
6	chr22:30631600-30636400	Enhancers	HSMM	muscle
7	chr22:30631800-30639400	Weak transcription	Sigmoid Colon	Sigmoid Colon
8	chr22:30632000-30636600	Weak transcription	Colonic Mucosa	Colon
9	chr22:30632000-30638600	Weak transcription	Rectal Mucosa Donor 29	rectum
10	chr22:30632000-30641400	Weak transcription	Cortex derived primary cultured neurospheres	brain
11	chr22:30632400-30638600	Weak transcription	Spleen	Spleen
12	chr22:30632400-30639600	Weak transcription	HUES64 Cell Line	embryonic stem cell
13	chr22:30632400-30640800	Weak transcription	Lung	lung
14	chr22:30632600-30639400	Weak transcription	NHDF-Ad	bronchial
15	chr22:30632600-30641000	Weak transcription	iPS-18 Cell Line	embryonic stem cell
16	chr22:30632600-30641400	Weak transcription	HUES48 Cell Line	embryonic stem cell
17	chr22:30632600-30645200	Weak transcription	Hela-S3	cervix
18	chr22:30632800-30637000	Weak transcription	HMEC	breast
19	chr22:30633000-30636800	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
20	chr22:30633600-30637200	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
21	chr22:30633600-30638400	Bivalent Enhancer	Fetal Muscle Leg	muscle
22	chr22:30633800-30640200	Weak transcription	Duodenum Smooth Muscle	Duodenum
23	chr22:30634000-30636600	Enhancers	Fetal Stomach	stomach
24	chr22:30634000-30637600	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
25	chr22:30634000-30638400	Bivalent Enhancer	Fetal Muscle Trunk	muscle
26	chr22:30634000-30640400	Weak transcription	Dnd41	blood
27	chr22:30634000-30646800	Genic enhancers	A549	lung
28	chr22:30634600-30636400	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
29	chr22:30634800-30636800	Enhancers	Breast Myoepithelial Primary Cells	Breast
30	chr22:30635000-30637400	Weak transcription	Fetal Thymus	thymus
31	chr22:30635000-30637400	Weak transcription	Stomach Mucosa	stomach
32	chr22:30635000-30639600	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
33	chr22:30635000-30639800	Genic enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
34	chr22:30635000-30641000	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
35	chr22:30635000-30641200	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
36	chr22:30635200-30636600	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
37	chr22:30635200-30636600	Weak transcription	Placenta Amnion	Placenta Amnion
38	chr22:30635200-30637200	Weak transcription	H1 Cell Line	embryonic stem cell
39	chr22:30635200-30638400	Weak transcription	Duodenum Mucosa	Duodenum
40	chr22:30635200-30638600	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
41	chr22:30635200-30638800	Weak transcription	Gastric	stomach
42	chr22:30635200-30639000	Genic enhancers	NHLF	lung
43	chr22:30635200-30639800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
44	chr22:30635200-30641000	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
45	chr22:30635200-30641800	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
46	chr22:30635400-30637000	Enhancers	HSMMtube	muscle
47	chr22:30635400-30637400	Weak transcription	HUES6 Cell Line	embryonic stem cell
48	chr22:30635400-30640800	Strong transcription	Fetal Intestine Small	intestine
49	chr22:30635600-30637000	Weak transcription	Fetal Intestine Large	intestine
50	chr22:30635600-30637200	Genic enhancers	Osteobl	bone

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links